Keywords: معیار ارزیابی پاسخ در تومورهای جامد; BM; brain metastasis; AE; adverse event; CI; confidence interval; CTLA4; cytotoxic T-lymphocyte antigen-4; CT; computed-tomography; GPA; Graded Prognostic Assessment score; IORR; intracerebral objective response rate; IQR; interquartile range; NSCLC; nonâ
مقالات ISI معیار ارزیابی پاسخ در تومورهای جامد (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: معیار ارزیابی پاسخ در تومورهای جامد; CI; confidential interval; CT; computed tomography; DECT; dual-energy computed tomography; GSI; gemstone spectral imaging; HU; hounsfield unit; NSCLC; non-small cell lung cancer; OR; odds ratio; RECIST; response evaluation criteria in solid tumors; ROC; r
Keywords: معیار ارزیابی پاسخ در تومورهای جامد; CT; computed tomography; PET; positron emission tomography; PA; posterior-anterior; CECT; contrast enhanced computed tomography; 18[F]-FDG; 18[F]-fluorodeoxyglucose; ROI; region of interest; MRI; magnetic resonance imaging; RECIST; response evaluation cri
Keywords: معیار ارزیابی پاسخ در تومورهای جامد; CI; confidence interval; CR; complete response; DC; disease control; OS; overall survival; PD; progressive disease; PR; partial response; RECIST; Response Evaluation Criteria in Solid Tumors; SD; stable disease; STS; soft tissue sarcoma; TARE; transarteri
Keywords: معیار ارزیابی پاسخ در تومورهای جامد; metastatic breast cancer; MBC; lobaplatin and gemcitabine; GL; lobaplatin and vinorelbine; NL; cisplatin and gemcitabine; GP; cisplatin and vinorelbine; NP; progression-free survival; PFS; overall survival; OS; response rate; RR; platinum-based compounds;
Keywords: معیار ارزیابی پاسخ در تومورهای جامد; DICOM; Digital Imaging and Communications in Medicine; GEMM; genetically engineered mouse model; KP; KRAS TP53; micro-CT; micro-computed tomography; MTC; mass of the thoracic cavity; PLK1; polo-like kinase 1; RECIST; Response Evaluation Criteria in Soli
Keywords: معیار ارزیابی پاسخ در تومورهای جامد; PD-1; programed cell death-1; PD-L1; programmed cell death ligand 1; NSCLC; non-small-cell lung cancer; OS; overall survival; PFS; progression-free survival; ORR; objective response rate; irAEs; immune-related adverse events; RECIST; response evaluation c
Keywords: معیار ارزیابی پاسخ در تومورهای جامد; BACE; bronchial arterial chemoembolization; CBM; China biological medicine database; CNKI; China national knowledge infrastructure database; CENTRAL; Cochrane Central Register of Controlled Trials; Chi-CTR; Chinese clinical trial registry; DCR; disease co
Keywords: معیار ارزیابی پاسخ در تومورهای جامد; CI; confidence interval; CRLM; colorectal cancer liver metastases; 18F-FDG; 18F-fluorodeoxyglucose; HR; hazard ratio; LTD; longest tumor diameter; NTL; nontarget lesion; OS; overall survival; PET; positron emission tomography; RE; radioembolization; RECIS
Keywords: معیار ارزیابی پاسخ در تومورهای جامد; EORTC; European Organization for Research and Treatment of Cancer; NCI-MATCH; National Cancer Institute- Molecular Analysis for Therapy Choice; RECIST; Response Evaluation Criteria In Solid Tumors; SITC; Society for ImmunoTherapy of Cancer; SPECTA; Screen
Keywords: معیار ارزیابی پاسخ در تومورهای جامد; Immunoassay; Serum biomarker; Cancer; Follow-up; Prognosis; Histotype; HE4; human epididymis protein 4; OC; ovarian cancer; CA125; carbohydrate antigen 125; HR; hazard ratio; PFS; progression-free survival; NCCN; National Comprehensive Cancer Network; GCI
Keywords: معیار ارزیابی پاسخ در تومورهای جامد; NSCLC; non small-cell lung cancer; EGFR; epidermal growth factor receptor; TKI; tyrosine kinase inhibitor; PFS; progression-free survival; ECOG; Eastern Cooperative Oncology Group; RECIST; Response Evaluation Criteria in Solid Tumors; ECG; electrocardiogr
Keywords: معیار ارزیابی پاسخ در تومورهای جامد; Rectal neoplasms; Chemoradiotherapy; Neoadjuvant therapy; Response evaluation criteria in solid tumors; Endoscopy;
Keywords: معیار ارزیابی پاسخ در تومورهای جامد; TACE; Transarterial Chemoembolization; cTACE; conventional Transarterial Chemoembolization; HCC; hepatocellular carcinoma; EASL; European Association for the Study of the Liver Guidelines; qEASL; 3D quantitative European Association for the Study of the L
Keywords: معیار ارزیابی پاسخ در تومورهای جامد; Clinical trial; cancer imaging; study design; statistical analysis; ACRIN; American College of Radiology Imaging Network; CT; computed tomography; ER; estrogen receptor; FDG; [18F]-fluorodeoxyglucose; FDG-PET; positron emission tomography with [18F]-fluor
Keywords: معیار ارزیابی پاسخ در تومورهای جامد; Castration-resistant prostate cancer; Response Evaluation Criteria in Solid Tumors; Response; Overall survival;
Keywords: معیار ارزیابی پاسخ در تومورهای جامد; Erythropoietin; Stem cell; Traumatic brain injury; EPO; Erythropoietin; GFAP; Glial fibrillary acidic protein; H&E; Hematoxylin and eosin; MRI; Magnetic resonance imaging; MSC; Mesenchymal stem cell; RECIST; Response Evaluation Criteria in Solid Tumors; S
Keywords: معیار ارزیابی پاسخ در تومورهای جامد; Local control; Spine radiosurgery; Spine surgery; Tumor; Wound infection; CT; Computed tomography; CTV; Clinical target volume; DRR; Digitally reconstructed radiograph; ESCC; Epidural spinal cord compression; IM; Infrared markers; MESCC; Metastatic epidur
Keywords: معیار ارزیابی پاسخ در تومورهای جامد; Epidermal growth factor receptor-tyrosine kinase inhibitor; Overall survival; Progression-free survival; Progressive disease; Response Evaluation Criteria in Solid Tumors
Keywords: معیار ارزیابی پاسخ در تومورهای جامد; ECOG; Eastern Cooperative Oncology Group; GGT; γ-glutamyltransferase; HR; hazard ratio; LdBM; liver dominant breast metastases; OS; overall survival; RECIST; Response Evaluation Criteria In Solid Tumors; TARE; transarterial radioembolization; TTEP; time
Keywords: معیار ارزیابی پاسخ در تومورهای جامد; SBRT; stereotactic body radiation therapy; HCC; hepatocellular carcinoma; RECIST; response evaluation criteria in solid tumors; CTCAE; common terminology criteria for adverse events; LC; local control; OS; overall survival; PFS; progression-free survival;
Keywords: معیار ارزیابی پاسخ در تومورهای جامد; BSA; body surface area; CEA; carcinoembryonic antigen; DWL; whole-liver absorbed dose; mCRC; metastatic colorectal carcinoma; RECIST; Response Evaluation Criteria in Solid Tumors; REILD; radioembolization-induced liver disease; SPECT; single photon emissi
Keywords: معیار ارزیابی پاسخ در تومورهای جامد; EGFR; epidermal growth factor receptor; NSCLC; non-small cell lung cancer; TKI; tyrosine kinase inhibitor; WT; wild type; KRAS; Kirsten RNA associated rat sarcoma 2 virus gene; PTEN; phosphatase and tensin homolog; HGF; hepatocyte growth factor; IGF1R; in
Keywords: معیار ارزیابی پاسخ در تومورهای جامد; AAV; adeno-associated viruses; Ad6; adenovirus serotype 6; ABCB5Â +; ATP-binding cassette sub-family B member 5; ALDH; aldehyde dehydrogenase; AML; acute myeloid leukemia; APCs; antigen presenting cells; B7.1; (CD80) cluster of differentiation 80; BCG; Ba
Clinical efficacy and safety of Aidi injection plus paclitaxel-based chemotherapy for advanced non-small cell lung cancer: A meta-analysis of 31 randomized controlled trials following the PRISMA guidelines
Keywords: معیار ارزیابی پاسخ در تومورهای جامد; ADRs; adverse drug reactions; AMI; astragalus membranaceus injection; CNKI; China national knowledge infrastructure database; CBM; China biological medicine database; CR; complete response; CI; confidence interval; CTCAE 3.0; Common Terminology Criteria f
A multicenter, open-label, phase II trial of S-1 plus carboplatin in advanced non-small cell lung cancer patients with interstitial lung disease
Keywords: معیار ارزیابی پاسخ در تومورهای جامد; ILD; interstitial lung disease; IPF; idiopathic pulmonary fibrosis; AE; acute exacerbation; AE-ILD; acute exacerbation of interstitial lung disease; NSCLC; non-small cell lung cancer; S-1; tegafur-gimeracil-oteracil potassium; CBDCA; carboplatin; RECIST;
Phase II study of tailored S-1 monotherapy with a 1-week interval after a 2-week dosing period in elderly patients with advanced non-small cell lung cancer
Keywords: معیار ارزیابی پاسخ در تومورهای جامد; ALK; anaplastic lymphoma kinase; ALT; alanine aminotransferase; AST; aspartate aminotransferase; BSA; body surface area; Ccr; creatinine clearance; CI; confidence interval; CR; complete response; CTCAE; common terminology criteria for adverse events; DCR;
Endoscopic criteria to evaluate tumor response of rectal cancer to neoadjuvant chemoradiotherapy using magnifying chromoendoscopy
Keywords: معیار ارزیابی پاسخ در تومورهای جامد; Endoscopic evaluation criteria for chemoradiotherapy; Watch and wait; Chemoradiotherapy; Rectal cancer; Response Evaluation Criteria in Solid Tumors; Endoscopic findings of complete response;
Intrahepatic Cholangiocarcinoma Treated with Transarterial Yttrium-90 Glass Microsphere Radioembolization: Results of a Single Institution Retrospective Study
Keywords: معیار ارزیابی پاسخ در تومورهای جامد; CA; cancer antigen; CI; confidence interval; ECOG; Eastern Cooperative Oncology Group; ICC; intrahepatic cholangiocarcinoma; INR; international normalized ratio; MELD; Model for End-Stage Liver Disease; OS; overall survival; RECIST; Response Evaluation Cr
Highly sensitive detection and mutational analysis of lung cancer circulating tumor cells using integrated combined immunomagnetic beads with a droplet digital PCR chip
Keywords: معیار ارزیابی پاسخ در تومورهای جامد; NSCLC; non-small cell lung cancer; SCC; lung squamous cell carcinoma; SCLC; small cell lung cancer; AC; adenocarcinoma; RECIST; response evaluation criteria in solid tumors; Circulating tumor cells (CTCs); Immuno-magnetic beads; Epithelial protein; Lung c
Diagnostic validation and interpretation of longitudinal circulating biomarkers using a biomarker response characteristic plot
Keywords: معیار ارزیابی پاسخ در تومورهای جامد; BReC plot; biomarker response characteristic plot; CEA; carcinoembryonic antigen; Cyfra 21.1; cytokeratin 19 fragment; RECIST; response evaluation criteria in solid tumors; CR; complete remission; PR; partial remission; SD; stable disease; PD; progressive
Nivolumab in advanced non-small-cell lung cancer patients who failed prior platinum-based chemotherapy
Keywords: معیار ارزیابی پاسخ در تومورهای جامد; AE; adverse event; ALK; anaplastic lymphoma kinase; ALT; alanine aminotransferase; AST; aspartate aminotransferase; CI; confidence interval; CR; complete response; ECOG; Eastern Cooperative Oncology Group; EGFR; epidermal growth factor receptor; HR; hazar
Prognostic value of radiologically enlarged lymph nodes in patients with metastatic colorectal cancer: Subgroup findings of the randomized, open-label FIRE-3/AIO KRK0306 trial
Keywords: معیار ارزیابی پاسخ در تومورهای جامد; AJCC; American Joint Committee on Cancer; AP; alkaline phosphatase; BRAF; v-Raf murine sarcoma viral oncogene homolog B; CI; confidence interval; CRC; (colorectal cancer); CT; computed tomography; ECOG; Eastern Cooperative Oncology Group scale of performa
Single-nucleotide polymorphisms in the genes of CES2, CDA and enzymatic activity of CDA for prediction of the efficacy of capecitabine-containing chemotherapy in patients with metastatic breast cancer
Keywords: معیار ارزیابی پاسخ در تومورهای جامد; 5â²DFCR; 5â²deoxy-5-fluorocytidine; 5â²DFUR; 5â²-deoxy-5-fluorouridine; 5-FU; 5-fluorouracil; AEs; adverse events; AML; acute promyelocytic leukemia; AU; arbitrary unit; CDA; cytidine deaminase; CES; carboxylesterase; DPD; dihydropyrimidine dehydrogen
CT-response patterns and the role of CT-textural features in inoperable abdominal/retroperitoneal soft tissue sarcomas treated with trabectedin
Keywords: معیار ارزیابی پاسخ در تومورهای جامد; CI; ConfidenceInterval; CT; ComputedTomography; CTTA; CT-TexturalAnalysis; DCR; Disease Control Rate; DNA; DeoxyribonucleicAcid; FDG-PET; Fludeoxyglucose-Positron Emission Tomography; Fig.; Figure; GIST; Gastrointestinal Stromal Tumor; NGLD; MNeighboring
Aidi injection plus platinum-based chemotherapy for stage IIIB/IV non-small cell lung cancer: A meta-analysis of 42 RCTs following the PRISMA guidelines
Keywords: معیار ارزیابی پاسخ در تومورهای جامد; NSCLC; non-small cell lung cancer; PBC; platinum-based chemotherapy; CR; complete response; PR; partial response; NC; no change; SD; stable disease; PD; progressive disease; ORR; objective response rate; DCR; Disease Control Rate; KPS; karnofsky performan
Uptake of Prostate-Specific Membrane Antigen (PSMA) in adenoid cystic carcinoma - Is PSMA-PET-CT a helpful tool in radiation oncology?
Keywords: معیار ارزیابی پاسخ در تومورهای جامد; ACC; Adenoid cystic carcinoma; CTCAE; Common terminology criteria of adverse events; IMRT; intensity modulated radiotherapy; HIT; Heidelberg Ion Beam Therapy Center; IHC; Immunohistochemistry; PET-CT; Positron emission tomography-computed tomography; PSMA
Randomized phase II trial of daily administration versus alternate-day administration of S-1 in patients with advanced non-small cell lung cancer
Keywords: معیار ارزیابی پاسخ در تومورهای جامد; FT; tegafur; CDHP; 5-chloro-2,4-dihydroxypyridine; Oxo; potassium oxonate; GI; gastrointestinal; ECOG; Eastern Cooperative Oncology Group; UFT; tegafur uracil; EGFR; epidermal growth factor receptor; BSA; body surface area; PD; progressive disease; CT; co
Predictive role of GSTP1-containing exosomes in chemotherapy-resistant breast cancer
Keywords: معیار ارزیابی پاسخ در تومورهای جامد; GSTP1; glutathione S-transferase P1; PD; progressive disease; SD; stable disease; PR; partial response; CR; complete response; TSG101; tumour susceptibility gene 101 protein; BCa; breast cancer; microRNA; miRNA; DNA; deoxyribonucleic acid; HSP70; heat sho
Intravoxel incoherent motion (IVIM) histogram biomarkers for prediction of neoadjuvant treatment response in breast cancer patients
Keywords: معیار ارزیابی پاسخ در تومورهای جامد; Breast cancer; Diffusion weighted MRI; Intravoxel incoherent motion; Neoadjuvant treatment; Response evaluation criteria in solid tumors;
Nivolumab-induced interstitial lung disease analysis of two phase II studies patients with recurrent or advanced non-small-cell lung cancer
Keywords: معیار ارزیابی پاسخ در تومورهای جامد; ILD; interstitial lung disease; EGFR; epidermal growth factor receptor; TKIs; tyrosine-kinase inhibitors; PD-1; programmed cell death-1; NSCLC; non-small-cell lung cancer; RECIST; Response Evaluation Criteria in Solid Tumors; CT; chest computed tomography
Role of dynamic contrast-enhanced and diffusion weighted MRI in evaluation of hepatocellular carcinoma after chemoembolization
Keywords: معیار ارزیابی پاسخ در تومورهای جامد; CT; computed tomography; MRI; magnetic resonance imaging; TACE; transarterial chemoembolization; DWI; diffusion weighted imaging; RECIST; response evaluation criteria in solid tumors; ADC; apparent diffusion coefficient; ROI; region of interest; TN; true
Treatment, outcome and quality of life of 1239 patients with advanced non-small cell lung cancer - final results from the prospective German TLK cohort study
Keywords: معیار ارزیابی پاسخ در تومورهای جامد; ALK; Anaplastic Lymphoma Kinase; BMI; body mass index; CCI; Charlson Comorbidity Index; CI; confidence interval; CR; complete response; CRISP; clinical research platform into molecular testing, treatment and outcome of non-small cell lung carcinoma patien
A randomized, open-label, Phase III clinical trial of nivolumab vs. therapy of investigator's choice in recurrent squamous cell carcinoma of the head and neck: A subanalysis of Asian patients versus the global population in checkmate 141
Keywords: معیار ارزیابی پاسخ در تومورهای جامد; AE; adverse event; CI; confidence interval; ECOG; Eastern cooperative oncology group; EORTC; European Organization for Research and Treatment of Cancer; HPV; human papilloma virus; HR; hazard ratio; IC; investigator's choice of therapy; IVRS; interactiv
Modified Response Evaluation Criteria in Solid Tumors and European Association for the Study of the Liver Criteria Using Delayed-Phase Imaging at an Early Time Point Predict Survival in Patients with Unresectable Intrahepatic Cholangiocarcinoma following
Keywords: معیار ارزیابی پاسخ در تومورهای جامد; CR; complete response; EASL; European Association for the Study of the Liver; ICC; intrahepatic cholangiocarcinoma; mRECIST; modified Response Evaluation Criteria In Solid Tumors; PD; progressive disease; PR; partial response; RECIST; Response Evaluation
Correlation of Technetium-99m Macroaggregated Albumin and Yttrium-90 Glass Microsphere Biodistribution in Hepatocellular Carcinoma: A Retrospective Review of Pretreatment Single Photon Emission CT and Posttreatment Positron Emission Tomography/CT
Keywords: معیار ارزیابی پاسخ در تومورهای جامد; AD; absorbed dose; CI; confidence interval; HCC; hepatocellular carcinoma; MAA; macroaggregated albumin; mRECIST; modified RECIST; PET; positron emission tomography; RDC; reproducibility coefficient; RE; radioembolization; RECIST; Response Evaluation Crit
Development of novel antigen receptors for CAR T-cell therapy directed toward solid malignancies
Keywords: معیار ارزیابی پاسخ در تومورهای جامد; CAR; chimeric antigen receptor; HLA; human leukocyte antigen; MHC; major histocompatibility complex; NCI CTCAE; National Cancer Institute Common Terminology Criteria for Adverse Events; NSG; NOD scid gamma; PBL; peripheral blood lymphocytes; RECIST; Respo
Radioembolization of Hepatic Malignancies: Background, Quality Improvement Guidelines, and Future Directions
Keywords: معیار ارزیابی پاسخ در تومورهای جامد; AFP; α-fetoprotein; ECOG; Eastern Cooperative Oncology Group; EASL; European Association for Study of the Liver; FDA; Food and Drug Administration; FDG; fluorodeoxyglucose; HCC; hepatocellular carcinoma; MAA; macroaggregated albumin; mRECIST; modified Re
Yttrium-90 Radioembolization for Breast Cancer Liver Metastases
Keywords: معیار ارزیابی پاسخ در تومورهای جامد; CTC; circulating tumor cell; GGT; γ-glutamyltransferase; MBC; metastatic breast cancer; OS; overall survival; PFS; progression-free survival; RECIST; Response Evaluation Criteria In Solid Tumors; WHO; World Health Organization;
Quantification of Rac1 and Rac1b in serum of non small cell lung cancer by label free real time assay
Keywords: معیار ارزیابی پاسخ در تومورهای جامد; NSCLC; Non Small Cell Lung Cancer; pre chemo; pre chemotherapy; Post chemo; post chemotherapy; SPR; surface plasmon resonance; EDC; N-ethyl-Nâ²-3diethylaminopropyl carbodiimide; NHS; N-hydroxysuccinimide; RU; response units; PVDF; polyvinylidene difluori